Chapter 58 Sleep Disorders
Clinical Case Problem 1 A 48-Year-Old Man with a 6-Month History of Snoring, Nocturnal Breath Cessations, and Excessive Daytime Sleepiness
Select the best answer to the following questions
1. What is the most likely diagnosis in this patient?
2. To what is the pathophysiology of this condition related?
3. This condition is accompanied by which of the following?
4. What is (are) the major symptom(s) of this disorder?
5. What is (are) the clinical feature(s) associated with the condition described?
6. What is (are) the factor(s) predisposing to this condition?
7. What is the treatment of first choice for this disorder?
8. Which of the following drugs is contraindicated in the treatment of the disturbed, nonrefreshing sleep that is associated with the condition described?
Clinical Case Problem 2 A 76-Year-Old Woman with an 8-Month History of Poor Sleep
9. What is your tentative diagnosis?
10. The patient is taking a total of 10 prescription medications. She is concerned that some of these could be causing her to not sleep well. Which of the following medications is not associated with insomnia?
11. The patient states that she had been living with her husband in the same house for the past 30 years. Her husband passed away 8 months ago. At that time, she insisted on continuing to live in the house alone with minimal help. She denies being depressed. What other symptom(s) besides insomnia would lead you to confirm your suspicion that the patient is depressed?
12. This patient wants some advice to improve her sleep. Which of the following is (are) a helpful tip(s)?
13. Besides sleep hygiene, is (are) there any other nonpharmacologic modality(ies) to treat chronic insomnia?
Clinical Case Management Problem
Discuss the principles of the use of hypnotic agents in the management of sleep disorders.
Answers
1. b. This patient has OSA. Polysomnography will confirm the diagnosis and will demonstrate disordered sleep with periods of apnea and hypopnea.
2. e. The pathophysiology of OSA syndrome includes the following: (1) the pharyngeal walls collapse repetitively during sleep, causing intermittent sleep-related upper airway obstruction and cessation in ventilation (apneas); (2) the cessation of ventilation is related to a concomitant loss of inspiratory effort; and (3) upper airway closure in OSA results from a failure of the genioglossus and other upper airway dilator muscles, and apnea results.
3. e. OSA produces the following acid-base balance situation: (1) apnea causes hypercarbia, hypoxemia, and a resulting respiratory acidosis; and (2) only if there is another preexisting condition associated with OSA will metabolic acidosis be produced.
4. f. The major symptoms of OSA syndrome are as follows: (1) loud snoring, (2) reports of prolonged pauses in respiration during sleep, (3) daytime hypersomnolence, (4) disturbed nonrefreshing sleep, and (5) weight gain.
5. e. Associated clinical features of OSA include systemic hypertension; inhibited sexual desire; impotence; ejaculatory impairment; depression; deficits in attention, motor efficiency, and graphomotor ability; deterioration in interpersonal relationships; marital discord; and occupational impairment.
6. d. Factors that predispose to OSA include sedating pharmacologic agents such as alcohol and benzodiazepines (all are contraindicated in OSA); nasal obstruction; large uvula; low-lying soft palate; retrognathia, micrognathia, and other craniofacial abnormalities; pharyngeal masses such as tumors or cysts; macroglossia; tonsillar hypertrophy; vocal cord paralysis; obesity; hypothyroidism; and acromegaly.
7. c. Polysomnography demonstrates that CPAP devices reverse apnea and hypopnea. In randomized controlled trials, CPAP devices also reduce daytime somnolence and improve mood and alertness. Compliance ranges from 50% to 80%. Although CPAP is the best choice of those listed, always recommend weight reduction in obese individuals.
8. c. The most established management options, in addition to weight loss, in order of preference are as follows: (1) CPAP, (2) UPP, and (3) tracheostomy. Additional measures are antidepressants that are stimulating, such as protriptyline, fluoxetine, sertraline, and paroxetine, particularly with coexistent depression. Chronic anxiety, which may complicate the OSA picture, should not be managed with benzodiazepines. Instead, the nonbenzodiazepine buspirone, which does not appear to aggravate OSA, should be used, along with behavioral treatments. Thus, alprazolam is contraindicated.
9. a. Chronic insomnia is defined as any insomnia lasting more than 6 months and is associated with a wide variety of disorders, including depression. More information is needed before depression can be diagnosed in this case.
10. a. Many medications are associated with insomnia (Table 58-1). However, Lipitor, a statin used to treat hyperlipidemia, does not have the side effect of insomnia.
11. e. Symptoms of depression include SIGECAPS: